Literature DB >> 11390203

Injection of human herpesvirus-8 in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions.

K E Foreman1, J Friborg, B Chandran, H Katano, T Sata, M Mercader, G J Nabel, B J Nickoloff.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) or human herpesvirus 8 (HHV-8) has been implicated in the development of Kaposi's sarcoma (KS) and several B-cell lymphoproliferative diseases. Serologic and molecular genetic association data has implicated HHV-8 as the causal agent of KS, but its role in the development of KS lesions is not understood. To examine the etiology of KS, HHV-8 was injected into normal human skin transplanted onto SCID mice. Injection of HHV-8 induced lesion formation that is morphologically and phenotypically consistent with KS, including the presence of angiogenesis and spindle-shaped cells latently infected with HHV-8. These findings suggest that HHV-8 is indeed the etiologic agent of KS, and that the virus plays an important role in initiation of this disease.

Entities:  

Mesh:

Year:  2001        PMID: 11390203     DOI: 10.1016/s0923-1811(01)00087-1

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  12 in total

Review 1.  Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Authors:  Hye-Ra Lee; Stacy Lee; Preet M Chaudhary; Parkash Gill; Jae U Jung
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 2.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

3.  KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice.

Authors:  Christopher H Parsons; Laura A Adang; Jon Overdevest; Christine M O'Connor; J Robert Taylor; David Camerini; Dean H Kedes
Journal:  J Clin Invest       Date:  2006-06-22       Impact factor: 14.808

Review 4.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 5.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

6.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells.

Authors:  Jun Tang; Gabriel M Gordon; Maike G Müller; Madhu Dahiya; Kimberly E Foreman
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  12E2: a cloned murine dermal cell with features of dermal dendrocytes and capacity to produce pathologic changes resembling early Kaposi's sarcoma.

Authors:  Masatoshi Deguchi; Diana Whitaker-Menezes; Stephen C Jones; Setsuya Aiba; Satoshi Nakagawa; Hachiro Tagami; Robert Korngold; George F Murphy
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

8.  Susceptibility of human fetal mesenchymal stem cells to Kaposi sarcoma-associated herpesvirus.

Authors:  Christopher H Parsons; Barbara Szomju; Dean H Kedes
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

9.  Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  Lin-Xu Wang; Guobin Kang; Pankaj Kumar; Wuxun Lu; Yue Li; You Zhou; Qingsheng Li; Charles Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

10.  Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.

Authors:  Liviu Feller; Johan Lemmer
Journal:  Infect Agent Cancer       Date:  2008-01-21       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.